Clinical trials
Phase 2 Overweight trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
144 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 12 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 9 |
| 2024 | 17 |
| 2025 | 27 |
| 2026 | 21 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 89 |
| Recruiting | 21 |
| Active, not recruiting | 14 |
| Terminated | 7 |
| Not yet recruiting | 5 |
| Unknown status | 3 |
| Withdrawn | 3 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 16 |
| AstraZeneca | 8 |
| The Miriam Hospital | 5 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 4 |
| Novo Nordisk A/S | 4 |
| Pfizer | 4 |
| Carmot Therapeutics, Inc. | 3 |
| Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 144 |
| Obesity | 133 |
| Weight Loss | 23 |
| Diabetes Mellitus, Type 2 | 15 |
| Insulin Resistance | 11 |
| Body Weight | 5 |
| Diabetes Mellitus | 5 |
| Hypertension | 5 |
| Metabolic Syndrome | 5 |
| Overnutrition | 5 |
Trials
Showing 1 to 25 of 144. Each trial links to its page on Pharma Observatory.
44 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.